Envista Holdings Co. (NYSE:NVST) Short Interest Down 13.8% in January

Envista Holdings Co. (NYSE:NVST) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 10,850,000 shares, a decline of 13.8% from the December 31st total of 12,580,000 shares. Based on an average trading volume of 2,070,000 shares, the short-interest ratio is currently 5.2 days.

Analyst Upgrades and Downgrades

NVST has been the topic of a number of recent research reports. Robert W. Baird increased their price objective on shares of Envista from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Stifel Nicolaus lifted their price target on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Jefferies Financial Group upped their price objective on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Piper Sandler lifted their target price on Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Envista has a consensus rating of “Hold” and a consensus price target of $20.13.

Envista Price Performance

NVST traded down $0.90 during trading on Friday, reaching $20.51. The company’s stock had a trading volume of 2,143,085 shares, compared to its average volume of 1,715,122. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The firm has a fifty day simple moving average of $20.08 and a two-hundred day simple moving average of $19.03. The company has a market cap of $3.53 billion, a price-to-earnings ratio of -2.64, a PEG ratio of 1.89 and a beta of 1.33. Envista has a 1 year low of $15.15 and a 1 year high of $24.79.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. During the same period in the prior year, the firm posted $0.43 earnings per share. The firm’s quarterly revenue was down 4.8% on a year-over-year basis. As a group, analysts anticipate that Envista will post 0.72 EPS for the current year.

Institutional Trading of Envista

Institutional investors and hedge funds have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Envista during the 3rd quarter worth $31,000. GAMMA Investing LLC grew its position in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after buying an additional 726 shares during the last quarter. Huntington National Bank raised its stake in Envista by 97.8% during the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after acquiring an additional 949 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in Envista by 528.4% in the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock valued at $38,000 after acquiring an additional 1,638 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.